|Bid||1.9100 x 3200|
|Ask||1.9300 x 4000|
|Day's range||1.8000 - 2.2000|
|52-week range||1.8000 - 6.3800|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 32% and 13.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Heron Therapeutics, Inc. ( NASDAQ:HRTX ) shareholders should be happy to see the share price up 12% in the last month...